Spotlight

Pro-Dex, Inc (NASDAQ: PDEX)

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We have patented adoptive torque-limiting software and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. […]

Spotlight

808 Renewable Energy Corporation (OTC Pink: RNWR)

808 Renewable Energy Corp is now changing the name to SilverLight International Group, along with the change of its stock symbol at the moment. The Company is now focusing on three business segments – gyrocopters, reverse-trikes and a new flying car concept in its existing manufacturing facility In Zephyrhills Regional Airport and the newly acquired production headquarters in Gatewood Corporate Center in Lakewood Ranch, Florida. […]

Spotlight

Citius Pharmaceuticals (NASDAQ: CTXR)

Myron Holubiak, CEO of Citius Pharmaceuticals took time to update WSA’s listeners on the companies’ progress since their previous interview. Mr. Holubiak provided an overview of the progress on the CTXR’s main products Mino-Lok and Mino-Wrap and shared how they are adapting the product to deal with COVID compliance and restrictions. He also talked about other programs in early stage development and went over key factors that make Citius a unique investment opportunity. Have a look below: […]

CEO Interviews

HPQ Silicon Resources Inc. (TSX-V: HPQ)(OTC : URAGF) Bernard Tourillon, Chairman, President and CEO

ABOUT: HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal, building a portfolio of unique high-value specialty silicon products needed for the coming RER. Working with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma-based processes. […]

Spotlight

Citius Pharmaceuticals (NASDAQ: CTXR) Profile and CEO Interview Update

Mino-Lok product has advanced to Phase 3 clinical studies. CITI-101 (Mino-Wrap) is a bio-absorbable film impregnated with minocycline and rifampin for reducing acute inflammation and microbial colonization of breast tissue expanders used in breast reconstruction surgeries following mastectomies. CITI-002 is being developed for symptomatic relief of hemorrhoids. CITI-002 combines the high-potency steroid, halobetasol, with lidocaine. […]

CEO Interviews

Natural Shrimp, Inc’s (OTC: SHMP) Patented Technology is in Place and the Company is Ready for Growth

About: NaturalShrimp, Inc. (OTCQB: SHMP) a publicly traded agro-tech company, has developed patented proprietary technology to produce fresh, gourmet-grade shrimp without the use of antibiotics, probiotics or toxic chemicals. NaturalShrimp systems are self-contained, saltwater production […]

Biotech

Anna Gluskin, CEO of Eastgate BioTech (OTC: ETBI) discusses positive results and how they are ready to take the Insulin market by storm.

“We’re doing a number of trials in Pakistan right now and the results that we announced just the other day; the end of the month, we’re showing a very good efficacy in absorption of product without injection.” […]